Furthermore, HL-60 is known to be less glycolytic compared to other AML cell lines, including THP-1 (38); the lower expression of TIM-3 on the M-3 subtype of AML may be the cause. The gene discussed is HAVCR2; the disease is acute myeloid leukemia.